https://ift.tt/2IVHF6y

The stock rallied 5% to Rs 732 on Thursday, extending its Wednesday's 2% gain on the BSE, after the company announced the acquisition of Sandoz's generic business in the US for $900 million.

from Markets https://ift.tt/2Nqpk3a

Comments

Popular posts from this blog

CAG flags tax irregularities by banks, NBFCs

Locust control eligible for SDRF and NDRF relief

IIT PhDs in demand for high-end R&D jobs